Abstract Details

Title Trends in Outcome and Hospitalization Charges of Pediatric Patients Admitted with Botulism in the United States. Data from Kids' Inpatient Database (KID) 1997-2009

Topic Infections/AIDS/Prion Disease

Presentation(s) P04 - (-)

Poster/Presentation
Number 005

Objective

Background BACKGROUND: New therapeutic strategies have been introduced in the last two decades to manage infantile botulism that are expected to improve the associated in-hospital outcomes.

Design/Methods DESIGN/METHODS: We determined the rates of occurrence, in-hospital outcomes, and mean hospital charges for infantile botulism patients hospitalized from 1997 to 2009 using Kids inpatient Database (KID).

Results RESULTS: The number of admissions for infantile botulism varied from 57 in 2003 to 80 in 2009. There was no significant difference in age and gender distribution during the study time period. Although there was a steady reduction in the length of hospitalization from 1997 to 2009, this reduction did not reach a statistical significance (minimum length of stay 11.86±11.03, maximum length of stay 17.86± 21.02 p 0.184). The vast majority of patients were discharged to home in all studied time periods. No death was observed in the study time period. There was a trend toward a significant increase in mean hospital charges from 1997 to 2009 (minimum charges $51,802± 66,226, maximum charges $132,568 ± 107,383 p. This difference persisted after adjustment for inflation.

Conclusions CONCLUSIONS: Despite a steady reduction in length of stay,,a significant increase in average hospitalization charges was observed in infantile botulism patients hospitalized from 1997 to 2009. This is probably related to the improvement of therapeutic strategies. Further work is needed for better understanding of national trends to allow appropriate resource allocation among patients with infantile botulism.

Authors/Disclosures
Nizar Souayah, MD, FAAN (NJMS) PRESENTER	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Rania A. Elenein, MD (Jefferson Health NJ)	Dr. Elenein has nothing to disclose.
Ludwig Kappos, MD, FAAN (RC2NB, University Hospital Basel)	Dr. Kappos has nothing to disclose.
Wenzhuan He, MD (UPMC Susquehanna Neurology)	Dr. He has nothing to disclose.

��ɫ��

��ɫ��